From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA panel: Expand approval of pneumococcal vaccine

from Internal Medicine News Digital Network

The majority of a Food and Drug Administration advisory panel supported expanding the approval of the pneumococcal 13-valent conjugate vaccine approved in 2010 for infants and children for use in adults aged 50 and older, based on studies using surrogate end points of effectiveness. The FDA's Vaccines and Related Biological Products Advisory Committee voted 14 to 1 that the immunogenicity data on the vaccine supported its effectiveness in preventing pneumococcal disease. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063